human cd19 magnetic bead sorting kit (Miltenyi Biotec)
Miltenyi Biotec is a verified supplier 
Miltenyi Biotec manufactures this product 
96
Structured Review
Miltenyi Biotec
human cd19 magnetic bead sorting kit
Human Cd19 Magnetic Bead Sorting Kit, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 96/100, based on 61 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sorting+cd19+microbead+kit/CD19+MicroBeads%2C+human+-+lyophilized/pmc04358086-33-1-11
Average 96 stars, based on 61 article reviews
Human Cd19 Magnetic Bead Sorting Kit, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 96/100, based on 61 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sorting+cd19+microbead+kit/CD19+MicroBeads%2C+human+-+lyophilized/pmc04358086-33-1-11
Average 96 stars, based on 61 article reviews
human cd19 magnetic bead sorting kit - by Bioz Stars,
2026-11
96/100 stars
Images
1) Product Images from "Constitutive activation of NF-κB signaling by NOTCH1 mutations in chronic lymphocytic leukemia"
Article Title: Constitutive activation of NF-κB signaling by NOTCH1 mutations in chronic lymphocytic leukemia
Journal: Oncology Reports
doi: 10.3892/or.2015.3762
Figure Legend Snippet: High expression of ICN proteins in the cytoplasm and nuclei of NOTCH1-mutated CLL cells, detected by immunofluorescence (x400). The images are representative of three (A) mutated and (B) five unmutated CLL cells. (C) In CLL cells carrying NOTCH1 mutations, the ICN protein was abundantly expressed in the cytoplasm and nuclei, at significantly higher levels than that observed in unmutated and normal CD19 + B cells ( * P<0.01).
Techniques Used: Expressing, Immunofluorescence
Related Articles
Magnetic Cell Separation:Article Title: Human immunodeficiency virus neutralizing antibodies and methods of use thereof Article Snippet: .. Briefly, CD19+ B cells were enriched from peripheral blood mononuclear cells using anti Article Title: Supplemental Information Universal allogeneic CAR T cells engineered with Sleeping Beauty transposons and CRISPR-CAS9 for cancer immunotherapy Article Snippet: Next, the cell supernatant containing secreted cytokines was harvested, and the cytokine levels were measured using the human MACSPlex Cytokine 12 Kit (Miltenyi Biotec, The Netherlands) and the human ELISA MAX Deluxe Set (Biolegend, The Netherlands). .. Alloreactivity assay To mitigate the CAR-mediated effector cell proliferation due to CD19 antigen stimulation, 30 Gy-irradiated bulk allogeneic PBMCs (allo-PBMCs) were subjected to CD19 depletion by MACS sorting using Article Title: DNAM-1 immunoreceptor integrates innate and adaptive immune programs to drive intestinal inflammation Article Snippet: .. After washing, cells were incubated with CD11b, CD34, CD56, CD14, CD16, and Staining:Article Title: Human immunodeficiency virus neutralizing antibodies and methods of use thereof Article Snippet: .. Briefly, CD19+ B cells were enriched from peripheral blood mononuclear cells using anti other:Article Title: Multiparametric Optimization of Human Primary B-Cell Cultures Using Design of Experiments. Article Snippet: The cell suspension was loaded onto pre- wetted Article Title: Universal allogeneic CAR T cells engineered with Sleeping Beauty transposons and CRISPR-CAS9 for cancer immunotherapy Article Snippet: A total of 2×105 CAR or control T cells was cocultured with the different target tumor cells at an effector:target ratio of 1:2 in 100 μL of phenol-free RPMI-1640 containing 0.1% BD GolgiStop Protein Transport Inhibitor-Monensin + PE Mouse Anti-Human CD107a, Clone H4A3 (BD Bioscience, Belgium). Magnetic Beads:Article Title: Prior SARS-CoV-2 infection affects adaptive immune responses to Omicron BA.4/BA.5 mRNA booster. Article Snippet: Prior SARS-CoV-2 infection affects adaptive immune responses to Omicron BA.4/BA.5 mRNA booster Brianna T. Wachter, BS, Qin Xu, MD, PhD, Lihong Shi, MD, Peter D. Burbelo, PhD, Kathy Myint-Hpu, PNP, Pamela L. Schwartzberg, MD, PhD, et al GRAPHICAL ABSTRACT Prior SARS-Cov-2 infection affects adaptive immune responses to Omicron BA.4/BA.5 mRNA booster.. Bivalent vaccine enhances levels of Spike-specific Abs Post bivalent vaccine: lower neutralization activity against the XBB1.5 SARS-CoV-2 variant Results Bivalent vaccine enhances Omicron-specific B cells in the COVID- group only 21 subjects Sp ik esp ec ifi c an tib od y le ve l S1 + R BD + B ce lls (% o f s m B ) RBD: Receptor Binding Domain; WT: wild type; TCR: T Cell Receptor; BCR: B Cell Receptor; IgG: immunoglobulin G pre-boost pre-boostpost-boost post-boost COVID - COVID+ pre prepost post COVID - COVID + C D 15 4+ IF N + ce lls (% o f C D 4+ ) pre-boost pre-boostpost-boost post-boost COVID - COVID+ Bivalent vaccine enhances Omicron-specific CD4+ T cells in the COVID- group only (COVID-) (COVID+) Capsule summary: In those vaccinated with the original coronavirus disease 2019 mRNA vaccine, hybrid immunity offers superior protection against severe acute respiratory syndrome coronavirus 2 variants; boosters should not be provided too soon after natural infection to maximize bivalent vaccine benefits.. J Allergy Clin Immunol 2025;155:2038-51. Article Title: Reciprocal METTL3-PAX5 regulation in maintaining B-cell identity and promoting B-cell hyperreactivity in SLE Article Snippet: CD138 depleted cells were stained with GL7-APC (Biolegend, 144618) then enriched using a positive immunomagnetic enrichment on APC (Miltenyi, 130-090−855). .. Derivative Assay:Article Title: Prior SARS-CoV-2 infection affects adaptive immune responses to Omicron BA.4/BA.5 mRNA booster. Article Snippet: Prior SARS-CoV-2 infection affects adaptive immune responses to Omicron BA.4/BA.5 mRNA booster Brianna T. Wachter, BS, Qin Xu, MD, PhD, Lihong Shi, MD, Peter D. Burbelo, PhD, Kathy Myint-Hpu, PNP, Pamela L. Schwartzberg, MD, PhD, et al GRAPHICAL ABSTRACT Prior SARS-Cov-2 infection affects adaptive immune responses to Omicron BA.4/BA.5 mRNA booster.. Bivalent vaccine enhances levels of Spike-specific Abs Post bivalent vaccine: lower neutralization activity against the XBB1.5 SARS-CoV-2 variant Results Bivalent vaccine enhances Omicron-specific B cells in the COVID- group only 21 subjects Sp ik esp ec ifi c an tib od y le ve l S1 + R BD + B ce lls (% o f s m B ) RBD: Receptor Binding Domain; WT: wild type; TCR: T Cell Receptor; BCR: B Cell Receptor; IgG: immunoglobulin G pre-boost pre-boostpost-boost post-boost COVID - COVID+ pre prepost post COVID - COVID + C D 15 4+ IF N + ce lls (% o f C D 4+ ) pre-boost pre-boostpost-boost post-boost COVID - COVID+ Bivalent vaccine enhances Omicron-specific CD4+ T cells in the COVID- group only (COVID-) (COVID+) Capsule summary: In those vaccinated with the original coronavirus disease 2019 mRNA vaccine, hybrid immunity offers superior protection against severe acute respiratory syndrome coronavirus 2 variants; boosters should not be provided too soon after natural infection to maximize bivalent vaccine benefits.. J Allergy Clin Immunol 2025;155:2038-51. Next-Generation Sequencing:Article Title: Prior SARS-CoV-2 infection affects adaptive immune responses to Omicron BA.4/BA.5 mRNA booster. Article Snippet: Prior SARS-CoV-2 infection affects adaptive immune responses to Omicron BA.4/BA.5 mRNA booster Brianna T. Wachter, BS, Qin Xu, MD, PhD, Lihong Shi, MD, Peter D. Burbelo, PhD, Kathy Myint-Hpu, PNP, Pamela L. Schwartzberg, MD, PhD, et al GRAPHICAL ABSTRACT Prior SARS-Cov-2 infection affects adaptive immune responses to Omicron BA.4/BA.5 mRNA booster.. Bivalent vaccine enhances levels of Spike-specific Abs Post bivalent vaccine: lower neutralization activity against the XBB1.5 SARS-CoV-2 variant Results Bivalent vaccine enhances Omicron-specific B cells in the COVID- group only 21 subjects Sp ik esp ec ifi c an tib od y le ve l S1 + R BD + B ce lls (% o f s m B ) RBD: Receptor Binding Domain; WT: wild type; TCR: T Cell Receptor; BCR: B Cell Receptor; IgG: immunoglobulin G pre-boost pre-boostpost-boost post-boost COVID - COVID+ pre prepost post COVID - COVID + C D 15 4+ IF N + ce lls (% o f C D 4+ ) pre-boost pre-boostpost-boost post-boost COVID - COVID+ Bivalent vaccine enhances Omicron-specific CD4+ T cells in the COVID- group only (COVID-) (COVID+) Capsule summary: In those vaccinated with the original coronavirus disease 2019 mRNA vaccine, hybrid immunity offers superior protection against severe acute respiratory syndrome coronavirus 2 variants; boosters should not be provided too soon after natural infection to maximize bivalent vaccine benefits.. J Allergy Clin Immunol 2025;155:2038-51. Purification:Article Title: Multiparametric Optimization of Human Primary B‐Cell Cultures Using Design of Experiments Article Snippet: Cell aliquots of human B cells were frozen in freeze medium (90% FBS, 10% DMSO) using the Corning CoolCell containers as recommended by the manufacturer. .. Incubation:Article Title: DNAM-1 immunoreceptor integrates innate and adaptive immune programs to drive intestinal inflammation Article Snippet: .. After washing, cells were incubated with CD11b, CD34, CD56, CD14, CD16, and Isolation:Article Title: Reciprocal METTL3-PAX5 regulation in maintaining B-cell identity and promoting B-cell hyperreactivity in SLE Article Snippet: CD138 depleted cells were stained with GL7-APC (Biolegend, 144618) then enriched using a positive immunomagnetic enrichment on APC (Miltenyi, 130-090−855). .. |